AI assistant
Dr. Lal Pathlabs Limited — Board/Management Information 2020
Feb 3, 2020
61783_rns_2020-02-03_0ee39659-2c72-453a-af9a-95e347bb126c.pdf
Board/Management Information
Open in viewerOpens in your device viewer

February 3, 2020
National Stock Exchange of India Limited Exchange Plaza, Plot No. C/1, G Block, Sandra Kurla Complex Sandra (E) Mumbai - 400 051
BSE Limited Corporate Relationship Department Phiroze Jeejeebhoy Towers Dalal Street Mumbai- 400001
Sub: Intimation of Re-designation & Appointment of Directors and KMP.
Ref: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI LODR Regulations")
Dear Sir/Madam,
Please take note that, based on recommendations of Nomination and Remuneration Committee, the Board of Directors in their meeting held today i.e February 3, 2020, approved the following matters:
-
- Re-designating (Hony) Brig. Dr. Arvind Lal by appointing him as Executive Chairman and Whole Time Director for a period of two (2) years, commencing from April 1, 2020 from his present designation of Chairman and Managing Director of the Company.
-
- Re-designating Dr. Om Prakash Manchanda by appointing him as Managing Director for a period of five (5) years, commencing from April 1, 2020 from his present designation of CEO & Whole-Time Director of the Company.
-
- Re-appointment of Dr. Vandana Lal as Whole-Time Director of the Company for a period of five (5) years, commencing from April 1, 2020.
-
- Re-designating Mr. Bharath Uppiliappan by appointing him as Chief Executive Officer (CEO) and Key Managerial Personnel (KMP), commencing from April 1, 2020 from his present designation of CEO (India Business) of the Company.

The Re-designation/Re-appoi_ntment of (Hony) Brig. Dr. Arvind Lal, Dr. Om Prakash Manchanda and Dr. Vandana Lal, is subject to approval of Shareholders of the Company.
Please also take note that (Hony) Brig. Dr. Arvind Lal, Dr. Om Prakash Manchanda and Dr. Vandana Lal are not debarred from holding the office of Director by virtue of any order of Securities and Exchange Board of India or any other such Authority.
Details as required under Regulation 30 of the SEBI LODR Regulations are a_ttached herewith as an Annexure A.
Thanking You, Yours Faithfully,
Rajat Kalra Company Secretary & Legal Head
Encl: As above

Annexure-A
$\frac{1}{2}$
| Particulars | (Hony) Brig. Dr. Arvind Lal | Dr. Om Prakash Manchanda | Dr. Vandana Lal | Mr. Bharath Uppiliappan |
|---|---|---|---|---|
| forReason | Re-designated as Executive | Re-designated as Managing Director of | Re-appointment as Whole Time | Re-designated as CEO & |
| Change | Chairman and Whole Time | the Company. | Director of the Company. | KMP of the Company. |
| Director of the Company. | ||||
| re-appointment of Dr.The | The re-designation of Mr. | |||
| ofDate | The re-designation of (Hony) | The re-designation of Dr. Om Prakash | Vandana Lal as Whole-Time | Bharath U as CEO & KMP |
| Appointment & | Dr.Arvind LalasBrig. | Manchanda as Managing Director shall | shall be effective from April 1, | |
| ofterm | ChairmanExecutiveand | be effective from April 1, 2020 for a | Director shall be effective from | |
| Appointment | Whole Time Director shall be | period of Five (5) years and is subject to | April 1, 2020 for a period of Five | 2020 and the terms of |
| effective from April 1, 2020 for | the approval of shareholders of the | (5) years and is subject to the | beappointmentshall | |
| a period of two (2) years and is | Company. The office of Dr. Om shall be | approval of shareholders of the | governed by the Company's | |
| subject to the approval of | liable to retire by rotation. | Company. The office of Dr. | policy. | |
| shareholders of the Company. | Vandana Lal shall be liable to | |||
| The office of (Hony) Brig. Dr. | retire by rotation. | |||
| Arvind Lal shall not be liable to | ||||
| retire by rotation. | ||||
| Brief Profile | (Hony) Brig. Dr. Arvind Lal is a | Dr. Om holds a bachelor's degree in | Dr. Vandana Lal is a promoter of | Mr. Bharath Uppiliappan |
| promoter of Dr. Lal PathLabs | veterinary science and animal husbandry | Dr. Lal PathLabs, she holds a | has been associated with | |
| and holds a bachelor's degree | from The Haryana Agricultural University, | bachelor's degree in medicine | sinceCompanythe | |
| in medicine and surgery from | Hisar and a postgraduate diploma in | and a bachelor's degree in | October 2016 in varying | |
| the University of Poona and a | management (agriculture) from the Indian | surgery from the University of | capacities. | |
| diploma in clinical pathology | Institute of Management, Ahmedabad | Delhi and a doctorate degree in | pathLabo | |
| ForcestheArmedfrom | ("IIMA"). | medicine (pathology) from the | $\sigma$ | |
| $\overline{a}$miteio.$\bullet$ |
$\ddot{\phantom{0}}$
$\sim 20$ $\sim$
$\mathcal{X}$
| Medical College, Pune. He After graduating from the IIMA in June University of Delhi. She has over | He is an Electrical and | |||
|---|---|---|---|---|
| has been conferred by the | 1990, he was selected as a management 33 years of experience in the | Electronics Engineer from | ||
| President of India an Honorary trainee for Lipton India Limited now field of pathology. | NIT Trichy and has a | |||
| Brigadier's rank in the Armed amalgamated into Hindustan Unilever | PGDM from SP Jain | |||
| Forces Medical Services and Limited ("HUL"}, under the management Dr. Vandana Lal is also trained in | Institute of Management | |||
| also the Padma Shri award. | trainee scheme of Unilever Group of I Quality | Assurance | and I & Research, Mumbai. In | |
| Companies in India. | spearheadsthequality | his 25 year career so far, | ||
| He has over 43 years of | implementation process in all the he has been focused on | |||
| experience in the field of | He has worked with HUL in various laboratories of Dr Lal PathLabs . | buildingbrandsand | ||
| Pathology and is recognized positions | suchasAreaManager, | She is the head of Clinical businesses across start | ||
| as a pioneer in bringing Innovation | Manager-Beverages, | Research Services being the up, | growthand | |
| laboratory services in India at | BusinessManager-LooseTea, | Chief Technical Officer since | turnaround phases with | |
| par with the western world. | Brookfields and Senior Product Manager. 2007, playing a pivotal role in industry | leading | ||
| Under his expert guidance and In HUL as a Senior Product Manager - | conception,planning, | companiesviz.FMCG | ||
| leadership, Dr. | Lal Innovation,hespearheaded | the construction,execution& | (Hindustan. Unilever Ltd}, | |
| PathLabs has become one of execution of Tea Based Beverage operationalizing the Clinical trials | Retailing (Bharti Walmart | |||
| the most reputed laboratories development project under the brand division. She also heads the - | BhartiRetailLtd) | |||
| in Asia, | name of Lipton Tiger. This innovation | Research & Development wing | Telecom(BhartiAirtel | |
| went on to win many awards viz., Unilever I of Dr Lal PathLabs by monitoring | Ltd.)inmultiple | |||
| He | brought | International I Central Asia and Mi_ddle East ("CAME") development of new tests and | categorieslike· Foods, | |
| recognitiontothe | Indian I Best Marketable Idea of the Year Award I methods. | Apparel, Home, Personal | ||
| Healthcare Industry in the in 1997, CAME Innovation Award for Best | Care,General | |||
| form of accreditation from the I Proven Initiative of the Year in 1998 and I She is the Executive Director of I Merchandise and telecom | ||||
| College | ofAmerican | Unilever Foods Innovation Award in | Dr. Lal PathLabs since 1995. | across both "India and |
| Pathologists (CAP -USA). | Beverages Category in the year 1999. | Herjobprofileincludes | Bharat" | |
| expansion of activities of the | ||||
| laboratory with assistance in | ' � _,,((]\ | |||
| -.J--;· |
, <.) ·,
| revolutionizedDr.Lalhas | Prior to joining Dr. Lal PathLabs, he has | planning and execution of new | ||
|---|---|---|---|---|
| medicinelaboratoryby | also worked with Monsanto India Limited | projects for the company; overall | ||
| introducingmaximumthe | as their National Marketing Manager and | charge of all the technical | ||
| numberoftests,new | Nationalthereafter astheirSales | departments ensuring accuracy, | ||
| ICTinstrumentsand | Manager. In January 2003 he joined | quality assurance, quality control | ||
| (Information, Communications, | Ranbaxy Laboratory Limited in their | & compliance to standards laid | ||
| Technology) systems. | Global Consumer Healthcare Division | down by the accreditation bodies | ||
| and worked initially as General Manager | like CAP, NABL & ISO. | |||
| - Marketing, Consumer Healthcare (India) | ||||
| and then General Manager - International | ||||
| & Innovation before joining Dr. Lal | ||||
| PathLabs in October 2005. | ||||
| Disclosureof | (Hony) Brig. Dr. Arvind Lal is | Dr. Om is not related to any Director of the | Dr. Vandana Lal is related to | Mr. Bharath Uppiliappan is not |
| relationships | related to Dr. Vandana Lal | Company. | (Hony) Brig. Dr. Arvind Lal | related to any Director of the |
| between | (Wife) and Dr. Archana Lal | (Husband) and Dr. Archana Lal | Company. | |
| Directors | Erdmann (Daughter) | Erdmann (Daughter) | ||
$\gamma_E$
$\mathcal{G}$
PathLabs $\Lambda\phi^{\prime}$ NEI $\overline{q}$
$\alpha$